Lumos Pharma, Inc. (LUMO) Earnings
|
Expand Research on LUMO
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -66.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/25  |
Q424 | N/A | -$0.45 | N/A | N/A | $5.33M | N/A | N/A | N/A | ||
| 11/25/24 |
Q324 | N/A | -$0.74 | N/A | N/A | $255.75K | N/A | N/A | N/A | ||
| 11/20/24 |
Q324 | N/A | -$0.74 | N/A | N/A | $255.75K | N/A | N/A | N/A | ||
| 11/19/24 |
Q324 | N/A | -$0.74 | N/A | N/A | $255.75K | N/A | N/A | N/A | ||
| 11/18/24 |
Q324 | N/A | -$0.74 | N/A | N/A | $255.75K | N/A | N/A | N/A | ||
| 11/15/24 |
Q324 | N/A | -$0.77 | N/A | N/A | $204.6K | N/A | N/A | N/A | ||
| 11/14/24 |
Q324 | N/A | -$0.77 | N/A | N/A | $204.6K | N/A | N/A | N/A | ||
| 11/13/24 |
Q324 | N/A | -$0.77 | N/A | N/A | $204.6K | N/A | N/A | N/A |
